But there are a lot of unknowns. If these drugs do get approved for MASH, which Sanyal anticipates could happen before the end of the year, Su wonders how long patients would need to be treated
Retatrutide adds glucagon receptor activity on top of GLP-1 and GIP signalling
Business Type Manufacturer, Supplier, Trading Company Employee Count 149 Establishment 2012 Working Days To GST NO 07BTEPP1689Q1ZS Payment Mode Cash Advance (CA), Others Related Products Explore Related Categories More Products From This Seller Seller Details GST - 07BTEPP1689Q1ZS New Delhi, Delhi Proprietor Ms Swati Singh Address B-No WZ T/1, Kailash Park, Main Najafgarh Road, Near Arya Samaj Mandir, New Delhi, Delhi, 110015, India Report incorrect details
The typical starting dose is 0.25 mg once weekly for four weeks, followed by an increase to 0.5 mg once weekly